Synbiotic Supplementation Containing Whole Plant Sugar Cane Fibre and Probiotic Spores Potentiates Protective Synergistic Effects in Mouse Model of IBD
Authors:
- Tanvi ShindeTSTanvi Shinde
- Agampodi Promoda PereraAPAgampodi Promoda Perera
- Ravichandra VemuriRVRavichandra Vemuri
- Shakuntla V. GondaliaSGShakuntla V. Gondalia
- Avinash V. KarpeAKAvinash V. Karpe
- David J. BealeDavid J. Beale
- Sonia ShastriSSSonia Shastri
- Benjamin SouthamBSBenjamin Southam
- Rajaraman EriRERajaraman Eri
- Roger StanleyRSRoger Stanley
Open Access
Abstract
Inflammatory bowel diseases (IBD) are a chronic inflammatory disorders with increasing global incidence. Synbiotic, which is a two-point approach carrying probiotic and prebiotic components in mitigating inflammation in IBD, is thought to be a pragmatic approach owing to the synergistic outcomes. In this study, the impacts of dietary supplementation with probiotic Bacillus coagulans MTCC5856 spores (B. coagulans) and prebiotic whole plant sugar cane fibre (PSCF) was assessed using a murine model of IBD. Eight-week-old C57BL/6 mice were fed a normal chow diet supplemented with either B. coagulans, PSCF or its synbiotic combination. After seven days of supplementation, colitis was induced with dextran sulfate sodium (DSS) in drinking water for seven days during the continuation of the supplemented diets. Synbiotic supplementation ameliorated disease activity index and histological score (−72%, 7.38, respectively), more effectively than either B. coagulans (−47%, 10.1) and PSCF (−53%, 13.0) alone. Synbiotic supplementation also significantly (p < 0.0001) prevented the expression of tight junction proteins and modulated the altered serum IL-1β (−40%), IL-10 (+26%), and C-reactive protein (CRP) (−39%) levels. Synbiotic supplementations also raised the short-chain fatty acids (SCFA) profile more extensively compared to the unsupplemented DSS-control. The synbiotic health outcome effect of the probiotic and prebiotic combinations may be associated with a synergistic direct immune-regulating efficacy of the components, their ability to protect epithelial integrity, stimulation of probiotic spores by the prebiotic fibre, and/or with stimulation of greater levels of fermentation of fibres releasing SCFAs that mediate the reduction in colonic inflammation. Our model findings suggest synbiotic supplementation should be tested in clinical trials.Keywords
Funding Information
- KFSU Ltd. (RT111031)
This publication has 80 references indexed in Scilit:
- Dextran Sodium Sulfate Inhibition of Real-Time Polymerase Chain Reaction Amplification: A Poly-A Purification SolutionInflammatory Bowel Diseases, 2012
- Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography–mass spectrometryNature Protocols, 2010
- Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double‐blind placebo‐controlled study in active Crohn’s diseaseAlimentary Pharmacology & Therapeutics, 2010
- Production of lactic acid from hemicellulose extracts by Bacillus coagulans MXL-9Journal of Industrial Microbiology and Biotechnology, 2010
- Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Nature, 2009
- Genes, diet and inflammatory bowel diseaseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environmentJournal of Gastroenterology, 2003
- Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporinDigestive Diseases and Sciences, 1993
- Rectal irrigation with short-chain fatty acids for distal ulcerative colitisDigestive Diseases and Sciences, 1991